REPORTS

Let’s Pullulate and Expand Your Business

Pharmaceutical Intermediates Market - Global Professional Analysis and Forecast to 2026

Oct 10, 2019  |  205 PAGES  |  REPORT CODE: CMM203144
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Pharmaceutical Intermediates market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.9% during the forecast period.

This report presents the market size and development trends by detailing the Pharmaceutical Intermediates market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharmaceutical Intermediates market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pharmaceutical Intermediates industry and will help you to build a panoramic view of the industrial development.

Pharmaceutical Intermediates Market, By Type:

  • Chiral Building Blocks

  • Achiral Building Blocks

Pharmaceutical Intermediates Market, By Application:

  • Pharmaceutical Companies

  • Research Labs

  • Contract Manufacturing Organizations

  • Other Industries

Some of the leading players are as follows:

  • Kuraray Europe GmbH

  • Derivados Químicos

  • Cambrex Corporation

  • Ercros

  • Lundbeck Pharmaceuticals

  • The WeylChem Group

  • Suntec Corporation

  • DSM Chemicals

  • Farmhispania

  • ICROM

  • CordenPharma

  • Menadiona

  • Sandoz

  • Centrient Pharmaceuticals

  • AGC

  • Uquifa

  • Aurobindo

  • BASF

  • SUANFARMA

  • Summit Pharmaceuticals Europe

  • Lonza

  • Interquim - Exquim, S.A.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Pharmaceutical Intermediates Market: Technology Type Analysis

  • 4.1 Pharmaceutical Intermediates Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Pharmaceutical Intermediates Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Chiral Building Blocks

    • 4.3.2 Achiral Building Blocks

5 Pharmaceutical Intermediates Market: Product Analysis

  • 5.1 Pharmaceutical Intermediates Product Market Share Analysis, 2018 & 2026

  • 5.2 Pharmaceutical Intermediates Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pharmaceutical Intermediates Market: Application Analysis

  • 6.1 Pharmaceutical Intermediates Application Market Share Analysis, 2018 & 2026

  • 6.2 Pharmaceutical Intermediates Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Pharmaceutical Companies

    • 6.3.2 Research Labs

    • 6.3.3 Contract Manufacturing Organizations

    • 6.3.4 Other Industries

7 Pharmaceutical Intermediates Market: Regional Analysis

  • 7.1 Pharmaceutical Intermediates Regional Market Share Analysis, 2018 & 2026

  • 7.2 Pharmaceutical Intermediates Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Kuraray Europe GmbH

    • 9.1.1 Kuraray Europe GmbH Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Derivados Químicos

    • 9.2.1 Derivados Químicos Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Cambrex Corporation

    • 9.3.1 Cambrex Corporation Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Ercros

    • 9.4.1 Ercros Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Lundbeck Pharmaceuticals

    • 9.5.1 Lundbeck Pharmaceuticals Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 The WeylChem Group

    • 9.6.1 The WeylChem Group Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Suntec Corporation

    • 9.7.1 Suntec Corporation Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 DSM Chemicals

    • 9.8.1 DSM Chemicals Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Farmhispania

    • 9.9.1 Farmhispania Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 ICROM

    • 9.10.1 ICROM Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 CordenPharma

    • 9.11.1 CordenPharma Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Menadiona

    • 9.12.1 Menadiona Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Sandoz

    • 9.13.1 Sandoz Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Centrient Pharmaceuticals

    • 9.14.1 Centrient Pharmaceuticals Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 AGC

    • 9.15.1 AGC Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Uquifa

    • 9.16.1 Uquifa Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Aurobindo

    • 9.17.1 Aurobindo Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 BASF

    • 9.18.1 BASF Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 SUANFARMA

    • 9.19.1 SUANFARMA Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Summit Pharmaceuticals Europe

    • 9.20.1 Summit Pharmaceuticals Europe Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Lonza

    • 9.21.1 Lonza Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

  • 9.22 Interquim - Exquim, S.A.

    • 9.22.1 Interquim - Exquim, S.A. Company overview

    • 9.22.2 Financial performance

    • 9.22.3 Product benchmarking

    • 9.22.4 Strategic initiatives

    • 9.22.5 SWOT analysis

 

The List of Tables and Figures (Totals 105 Figures and 131 Tables)

  • Figure Chiral Building Blocks Pharmaceutical Intermediates market, 2015 - 2026 (USD Million)

  • Figure Achiral Building Blocks Pharmaceutical Intermediates market, 2015 - 2026 (USD Million)

  • Figure Pharmaceutical Companies market, 2015 - 2026 (USD Million)

  • Figure Research Labs market, 2015 - 2026 (USD Million)

  • Figure Contract Manufacturing Organizations market, 2015 - 2026 (USD Million)

  • Figure Other Industries market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Kuraray Europe GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Derivados Químicos Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cambrex Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ercros Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lundbeck Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table The WeylChem Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Suntec Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DSM Chemicals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Farmhispania Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ICROM Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CordenPharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Menadiona Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sandoz Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Centrient Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AGC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Uquifa Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aurobindo Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BASF Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SUANFARMA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Summit Pharmaceuticals Europe Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lonza Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Interquim - Exquim, S.A. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top